|
⚲
|
| Keyboard |
| Lin Kenneth
✚
|
|
|---|---|
| CIK # | 0001770623 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001770623] | |
| 4 | [0001770623] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Anebulo Pharmaceuticals Inc | |
| Lin Kenneth | |
| Merrimack Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2025-04-04 | Grant | 25,000 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2025-04-04 | Grant | 4,964 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 41,667 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 2,482 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2022-04-21 | Grant | 30,425 | $0.00 |